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ABSTRACT The production of pro-inflammatory cy-
tokines, such as interleukin-1 and tumor necrosis fac
tor, is pivotal in the response to infection. However,
overproduction of these cytokines might be detrimen
tal. It has been suggested that (n-3) fatty acids sup
press inflammation and ameliorate the course of infec
tion by decreasing the production of pro-inflammatory
cytokines. We here, review these effects, use of (n-3)
fatty acids induced moderate clinical improvements in
rheumatoid arthritis, psoriasis and colitis, but not in
systemic lupus erythematosus. Data on critically ill
burn or postoperative cancer patients are still inconclu
sive. The (n-3) fatty acids markedly inhibited sterile
inflammation in animal studies and improved survival
in some experimental infections. T cell responses de
creased in healthy volunteers but remained unchanged
or increased in certain patient groups. The production
of pro-inflammatory cytokines decreased in most hu
man studies. The (n-3) fatty acids increased cytokine
production capacity in mice. Differences in cytokine-
producing cell types studied may account for these
paradoxical responses in humans and mice. Although
the increased cytokine production in mice is partly me
diated by effects on prostaglandins, mechanisms of
action in other species remain to be elucidated. The
(n-3) fatty acids may be of moderate benefit in some
chronic inflammatory diseases. Their therapeutic value
and possible hazards in critically ill patients remain to
be established. J. Nutr. 126: 1515-1533, 1996.
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The (n-3) polyunsaturated fatty acids have been in
vestigated for use in the treatment of inflammatory
diseases such as rheumatoid arthritis, psoriasis and ul
cerative colitis. Presently, enterai tube feeding prepara
tions containing relatively large amounts of (n-3) fatty
acids are advanced for use in critically ill patients be
cause of the presumed anti-inflammatory effects of
these fatty acids (Cerra et al. 1991a and 1991b, Daly et
al. 1992, Gottschlich et al. 1990). Although the anti-
inflammatory effects of (n-3) fatty acids originally were
attributed to changes in the production of prostaglan
dins and leukotrienes (Kinsella et al. 1990, Lee et al.
1985, Needleman et al. 1979), recent studies have em
phasized reduced production of cytokines as a possible
mechanism (Billiar et al. 1988, Endres et al. 1989). Here,
we review studies in humans and animals on the effects
of (n-3) fatty acids on inflammation, resistance to infec
tion, and cytokine production.
CYTOKINES AND INFLAMMATION
Cytokines are small proteins that are produced by a
variety of cell types. They act on nearly every tissue
and organ system. The cytokines interleukin-la (IL-
la),2 interleukin-IÃŸ (IL-1/3), tumor necrosis factor a
(TNF) and interleukin-6 (IL-6) are often designated pro-
inflammatory cytokines. They are mainly produced by
the mononuclear phagocytic cells, including both cir
culating monocytes and tissue macrophages. These cy
tokines mediate the response of the host to inflamma
tory stimuli. They induce fever, activation of B and T
lymphocytes and endothelial cells, synthesis of acute
phase proteins by the liver, and many other effects that
are all part of the acute phase response (Table 1) (Dinar-
elio 1991). The term "acute phase response" refers to
a set of local and systemic neurologic, endocrine and
metabolic changes through which the organism reacts
to various stimuli, including infections, forms of sterile
1To whom correspondence should be addressed.
2Abbreviations used: IL-1, interleukin-1; IL-2, interleukin-2; IL-
6, interleukin-6; LTB4, leukotriene B4; PGE2, prostaglandin E2; SLE,
systemic lupus erythematosus; TNF, tumor necrosis factor.
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TABLE 1
Biologica! effects of the pro-inflammatory cytokines interleukin-l
(IL-1), tumor necrosis factor (TNF) and interleukin-6 (IL-6)1
Biological effect IL-1 TNF IL-6
Induction of fever in experimental animals ++ + + +
and humans
Production of acute phase proteins by the + + + +
liver
Activation of T lymphocytes + + + + +
Activation of B lymphocytes ++ + + +
Activation of hematopoiesis + +
Gene expression of cyclooxygenase and + +
phospholipase A22
Activation of endothelial cells + +
Activation of synovial cells (e.g., collagenase + + +
production)
Osteoclast activation (bone rÃ©sorption) + +
Induction of hypotension + +
Induction of IL-1, TNF, IL-6 and IL-8 + +
1 - indicates that the effect is absent, + indicates a moderate
effect, ++ indicates a strong effect.
2 The induction of these enzymes is pivotal in the formation of
the so-called lipid mediators: prostaglandins, leukotrienes and plate
let-activating factor.
inflammation such as auto-immune disease, bleeding,
injury (e.g., burn trauma and major surgery) and heavy
exercise. The early events in the acute phase response
are local and serve to check bleeding, to demarcate
damaged tissues and to recruit cells for the subsequent
reparative phase, which requires a systemic response.
This second, systemic phase involves fever, anorexia,
leukocytosis and metabolic changes that include an
increased flow of amino acids from muscle to liver and
a rearrangement of the pattern of protein synthesis in
the liver: albumin production decreases and acute
phase proteins such as fibrinogen, C-reactive protein
and serum amyloid A are synthesized. Their appear
ance in the plasma contributes to a well-known phe
nomenon in inflammation: the elevated erythrocyte
sedimentation rate.
Most of these changes are mediated by IL-1, TNF
and IL-6. They can trigger cells to secrete other in
flammatory mediators, including other cytokines such
as the T lymphocyte products interferon gamma and
interleukin-2 (IL-2) and lipid mediators such as prosta
glandins, leukotrienes and platelet-activating factor.
Elevated plasma concentrations of IL-6, TNF or IL-1
have been observed in patients with infections, endo-
toxemia, trauma or burns, but also in acute bouts of
auto-immune disease such as rheumatoid arthritis or
systemic lupus erythematosus (SLE)and in patients un
dergoing organ transplant rejection (Dinarello 1992).
Increased IL-1 production by peripheral blood mononu-
clear cells and by colonie mononuclear cells has been
reported in patients with active inflammatory bowel
disease (Mahida et al. 1989, Mazlam and Hodgson
1992).
Although production of pro-inflammatory cytokines
is believed to benefit the host defense system, high
concentrations of circulating pro-inflammatory cyto
kines have been shown to correlate with poor outcome
in severe disease states such as meningococcal septic
shock (Waage et al. 1987 and 1989), other forms of sep
tic shock (Calandra et al. 1990, Cannon et al. 1990) and
cerebral malaria (Grau et al. 1989). Elevated concentra
tions of circulating or in vitro stimulated TNF and IL-
1 were also reported in AIDS patients by several groups
(Berman et al. 1987, Lahdevirta et al. 1988, Lepe-Zuniga
et al. 1987, Wright et al. 1988), although not by others
(Molina et al. 1989 and 1990). Anti-cytokine strategies
such as treatment with antibodies against TNF and
treatment with the interleukin-l receptor antagonist
were shown to reduce the severity of inflammation and
to protect against mortality in animal models of septic
shock, cerebral malaria and colitis (Comincili et al.
1990, Curfs et al. 1992, Grau et al. 1989, Ohlsson et
al. 1990, Tracey et al. 1987). From these observations,
the concept of "lethal cytokinemia" has emerged,
which implies that exaggerated cytokine production
may be harmful or even lethal (van der Meer 1989). It
is also felt that the chronically elevated concentrations
of cytokines in rheumatoid arthritis contribute to the
perpetuating inflammation and are harmful to the pa
tient (Eastgate et al. 1988, Firestein and Zvaifler 1992).
These observations have caused researchers to investi
gate the possible benefits of reducing cytokine produc
tion capacity through dietary intervention; of such in
terventions, the use of very long chain essential fatty
acids of the (n-3) family has received considerable at
tention.
(n-3) FATTY ACIDS AND
INFLAMMATION IN HUMANS
Table 2 summarizes studies on the effects of dietary
(n-3) fatty acids in inflammatory disease states in hu
mans. Several investigators have developed tube feeding
formulas with, among other modifications, (n-3) fatty
acids as the major lipid source. These modified formulas
have been investigated in bum patients (Gottschlich et
al. 1990) and patients operated on for upper gastrointesti
nal malignancies (Daly et al. 1992). Both studies claimed
reduction in infectious complications and in the length
of hospital stay. However, both studies were not double
blind, and disease severity or age were not evenly distrib
uted between the study groups, hi a better controlled
study by Moore et al. (1994), trauma patients receiving
a modified formula high in (n-3) fatty acids experienced
fewer intra-abdominal abscesses and less multiple organ
failure.
In placebo-controlled studies, patients with rheuma
toid arthritis experienced small improvements of
symptoms after ingestion of a fish oil concentrate for
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periods ranging from 8 to 24 wk. However, hard end-
points such as erythrocyte sedimentation rate, concen
tration of circulating acute phase proteins, and rheuma
toid factor titer were not influenced by dietary fish
oil supplementation. Similarly, minimal to moderate
clinical improvements were reported in patients with
psoriasis, bronchial asthma and ulcerative colitis after
dietary supplementation with fish oil.
Even less convincing are the results on fish oil feed
ing in patients with SLE (Moore et al. 1987). In one
double-blind, crossover study using olive oil as the con
trol, patients with moderately active SLE showed sig
nificant clinical and serological benefits after 3 mo of
fish oil consumption, but after 6 mo there was no differ
ence between the treatment groups (Westberg and Tar-
kowski 1990). Dietary fish oil supplementation had no
effect on renal outcome in patients with SLE-associated
nephritis (Clark et al. 1989).
Taken together, these studies suggest some attenua
tion of inflammation and thus of the acute phase re
sponse by (n-3) fatty acids in humans. However, the
rise in concentration of circulating acute phase pro
teins induced by heavy exercise was increased in
healthy volunteers after 3 wk of dietary supplementa
tion with (n-3)fatty acids (Ernst et al. 1991), suggesting
increased rather than decreased formation of pro-in
flammatory mediators after fish oil.
Thus, (n-3) fatty acids seem to have some beneficial
effects in rheumatoid arthritis, psoriasis and ulcerative
colitis, but only after prolonged ingestion, and labora
tory indices of inflammation were not affected. The ef
fects in bronchial asthma and SLEwere minimal to ab
sent. Data on short-term treatment with (n-3)fatty acids
in burn patients and in postoperative cancer patients are
still inconclusive, although the results of one study in
trauma patients are promising (Moore et al. 1994).
(n-3) FATTY ACIDS AND
INFLAMMATION IN ANIMALS
Studies on the effects of dietary (n-3) fatty acids in
experimental inflammations in animals are summa
rized in Table 3. Several studies have shown favorable
effects of dietary fish oil supplementation in mouse
models of SLE. These genetically susceptible mice
spontaneously develop a SLE-like syndrome including
glomerulonephritis, and the animals die before reach
ing 1 y of age. Administration of fish oil convincingly
retarded both the development of glomerulonephritis
and premature death (Kelley et al. 1985, Prickett et al.
1981). In a model of autoimmune arthritis in mice,
dietary fish oil supplementation reduced the severity
of joint inflammation (Leslie et al. 1985). However, in
similarly afflicted rats this effect was absent (Prickett
et al. 1984). In mice immunized with collagen, plasma
concentrations of amyloid P component, an acute
phase protein, were significantly reduced following a
fish oil diet (Cathcart et al. 1987). Inflammatory re
sponses have been implicated in the etiology of nonin-
sulin-dependent diabetes mellitus. In BHE rats, an ani
mal model of noninsulin-dependent diabetes mellitus,
longevity was shortened after a life-long fish oil diet
(Berdanier et al. 1992). However, the development of
glucose intolerance and lipemia was delayed in these
animals. Rats with immune complex-induced enter-
opathy developed significantly fewer severe inflam
matory lesions after a fish oil diet than after a beef
tallow diet (Bloch et al. 1989).Thus, most animal stud
ies demonstrated a modulating effect of (n-3)fatty acids
on inflammation.
Exogenous administration of IL-1 or TNF to experi
mental animals induces an acute phase response, in
cluding anorexia and fever (McCarthy et al. 1985, Mol-
dawer et al. 1988, Tracey et al. 1988).Apart from inter
ference with cytokine production, dietary fish oil
supplementation has been associated with attenuation
of some of the responses to exogenously administered
cytokines. In guinea pigs, the febrile response to an
injection of recombinant murine IL-1 was attenuated
after 6 wk of a fish oil-enriched diet compared with
control diet (Pomposelli et al. 1989). In rats, feeding
fish oil for 6 wk attenuated the catabolic response to a
combined infusion of IL-1 and TNF, as reflected by
reduced whole-body leucine oxidation and increased
net hepatic protein anabolism (Hirschberg et al. 1990).
Similarly, the anorexia induced by IL-1 administration
was markedly decreased in rats fed fish oil for 6 wk
(Hellerstein et al. 1989), and thermogenic and pyro-
genic responses to IL-1 were inhibited in rats after 4 to
9 wk of (n-3) fatty acid supplementation (Cooper and
Rothwell 1993).These fish oil effects may be mediated
by a reduced formation of prostaglandins, because both
IL-1-induced fever and anorexia are attenuated by
treatment with cyclooxygenase inhibitors (Hellerstein
et al. 1989, Okusawa et al. 1988).
Thus, in several animal models of auto-immune dis
ease and in experimentally induced acute phase re
sponse, severity of inflammation seems to be favorably
influenced by fish oils. In these animal studies, the
effects of (n-3) fatty acids seem much stronger than in
the clinical studies mentioned above. This difference
could relate to the fact that most of these studies in
volve feeding experimental diets to the animals before
the appearance of any disease symptoms, whereas stud
ies in humans have exclusively examined the activity
of (n-3) fatty acids against a background of an existing
clinical disease. Moreover, the relative amount of (n-
3) fatty acids ingested in the animal studies is substan
tially higher than in the human studies.
(n-3) FATTY ACIDS AND IMMUNE
RESPONSE
Does such a suppression of sterile inflammation co
incide with a general downregulation of the immune
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1520 BLÃ–K ET AL.
response, thereby decreasing host resistance to infec
tion? This question has been addressed in various ways.
In several studies, human peripheral blood mononu-
clear cells from healthy volunteers were cultured in
vitro. In these studies, T cell proliferation was inhib
ited by the addition of (n-3) fatty acids to the culture
medium (Calder et al. 1994, Soyland et al. 1993). In
vivo studies on peripheral blood mononuclear cells
after dietary supplementation with (n-3) fatty acids are
summarized in Table 4. Most studies in healthy volun
teers show a decreased proliferative response of T lym
phocytes to specific stimulants such as phytohemag-
glutinin or concanavalin A. The production capacity of
T cell-derived cytokines and the T4/T8 ratio were
found to be unchanged or depressed. On the other hand,
studies in certain patient groups such as asthma pa
tients and intensive care unit patients found a positive
effect of dietary (n-3) fatty acids on T cell responses.
One recent study even reported increased production of
interferon-y following consumption of (n-3) fatty acids
(Kemen et al. 1995). At present it is unclear why T
cell responses to dietary (n-3) fatty acids differ between
healthy subjects and certain patient groups. Depressed
T cell responses at baseline may play a role here. Well-
controlled studies comparing different patient groups
with healthy volunteers at baseline and after consump
tion of dietary (n-3) fatty acids are certainly needed to
clarify this issue.
Because decreased T cell functions may affect resis
tance to cancer, the possible impact of dietary (n-3)
fatty acids on carcinogenesis has been of concern. Epi-
demiological studies show that total fat intake is re
lated to breast and colon cancer mortality (Kromhout
1990, Wynder et al. 1986). Animal studies suggest that
(n-6) fatty acids may have a tumor-promoting effect
and that (n-3) fatty acids may exert an inhibitory effect
on chemically induced mammary and colon tumori-
genesis (Carroll and Braden 1984). In a recent human
study, low tissue levels of a-linolenic acid [18:3(n-3)J
were found to be associated with early metastasis in
breast cancer, suggesting a protective effect of (n-3)
fatty acids (Bougnoux et al. 1994). At present it is not
clear whether the effects of dietary (n-3) fatty acids on
carcinogenesis are related to their influence on T cell
function.
The incidence of certain infectious diseases such as
tuberculosis and diarrheal diseases has reportedly been
increased in Eskimo populations. Because many socio-
economic and genetic factors contribute to the inci
dence of infectious diseases, it is difficult to establish
the contribution of dietary (n-3) fatty acids to this phe
nomenon (Grzybowski and Dorken 1983).
In animal studies, the effects of dietary (n-3) fatty
acids on infections have been investigated with live
pathogenic microorganisms or bacterial endotoxins,
because Gram-negative bacteria such as Escherichia
coli and meningococci are pathogenic largely because
of the endotoxins that they release. In controlled stud
ies, guinea pigs were protected against metabolic acido-
sis and death from endotoxin administration when
they had been fed a fish oil-supplemented diet for 6
wk (Mascioli et al. 1989, Teo et al. 1991), and the physi
ological response to endotoxin infusion was favorably
influenced when guinea pigs had been on total paren-
teral nutrition containing (n-3) fatty acids for only 3.5
d prior to administration of endotoxin (Pomposelli et
al. 1990) (Table 5). Two studies reported a negative
effect of (n-3) fatty acids on outcome of experimental
infection with live microorganisms. Chang et al. (1992)
observed a decreased survival rate of fish oil-fed Swiss
mice infected perorally with Salmonella typhimurium,
and D'Ambola et al. (1991) reported diminished lung
clearance of inspired Staphylococcus aureus in neona
tal rabbits supplemented with high dose of fish oil or
safflower oil. However, most studies indicate that the
anti-inflammatory effect of dietary fish oil supplemen
tation in animals in general does not lead to an in
creased susceptibility to infection, and in several mod
els of infection, outcome was even improved (Fig. 1)
(Table 5). This suggests that in certain cases (n-3) fatty
acids will prevent the excessive production of cyto
kines that, if unchecked, leads to death in septic ani
mals.
(n-3) FATTY ACIDS AND CYTOKINE
PRODUCTION
Methodological problems
Cytokine assays and their validity. Cytokines can
exert their effects at extremely low concentrations (ng/
L), and under normal physiological conditions (e.g., in
the absence of disease or trauma) circulating cytokines
are often below the detection limits for most assay
systems. Therefore, in many clinical studies with
healthy human subjects cytokine-producing cells are
isolated, cultured and then stimulated in vitro to ob
tain detectable cytokine concentrations. Such studies
tell us more about the cytokine production capacity of
a given cell type in vitro than about changes in actual
cytokine production occurring in vivo.
In most human studies, peripheral blood mononu
clear cells are isolated using a density gradient. Subse
quently, these cells are cultured for a short period (e.g.,
overnight) and stimulated to produce cytokines. In
many animal studies, resident macrophages are iso
lated from the peritoneal cavity or from organs such as
the liver (Kupffer cells). Although culture principles for
human and animal cells are basically the same, it can
not be excluded that the differences in origin of these
cells have some bearing on their cytokine production
capacity in vitro.
Cytokines can be quantified by bioassay or by immu-
nochemical methods. In bioassays, cell lines are used
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24 48 72 96 120 144
Hours after infection with K.pneumoniae
FIGURE 1 Survival of Swiss mice after Klebsiella pneu-
moniae infection. Fish oil-fed animals survived significantly
longer than control animals fed palm oil, corn oil or nonpuri-
fied diet (P < 0.05). Reproduced with permission from Blok
et al. (1992).
that are dependent on specific cytokines for growth.
Such bioassays can detect cytokines at low concentra
tions, but their specificity is poor. More recently, the
availability of specific monoclonal and polyclonal anti
bodies against various cytokines has enabled the devel
opment of immunological detection methods such as
ELISA and RIA. In body fluids, cytokines may be bound
to specific proteins such as soluble receptors for TNF
or to nonspecific ligands such as al macroglobulin and
uromodulin. Such molecules may interfere with both
bioassays and immunoassays. Receptor blocking mole
cules such as the naturally occurring protein desig
nated IL-1 receptor antagonist interfere with bioassays
only (Dinarello 1991). On the other hand, with ELISA
and RIA one might be measuring biologically non-ac
tive proteins. In general, the reproducibility and valid
ity of immunoassays are superior to those of bioassays.
Design of dietary trials. Several human studies
evaluating the influence of (n-3) fatty acids on cytokine
production have compared baseline values with post-
treatment values, without a concurrent control group.
The contribution of aspecific fluctuations in cytokine
production such as reduced stress through adaptation
to the study protocol cannot be appreciated in such a
before-and-after design. It also cannot be deduced from
such studies whether the observed effects are specific
for the type of polyunsaturated fatty acids employed.
On the other hand, in placebo-controlled studies the
type and amount of placebo fatty acids may be problem
atic. In human studies, the dietary fat supplementation
constitutes only a small percentage of the total energy
intake, but in animal studies the fat supplement may
account for 30% of total energy intake. When control
groups receive such an amount of corn oil or safflower
oil, both very rich in (n-6) fatty acids, this may well
influence the production of prostaglandins and leuko-
trienes and thus may have some bearing on the resul
tant cytokine production measured in these studies
(Kinsella et al. 1990). Ideally, in both human and ani
mal supplementation studies, control groups should re
ceive an isoenergetic quantity of fatty acids without
disturbing the ratio of (n-3) to (n-6) fatty acids that was
present in their diets before the start of the study.
The effects of (n-3) fatty acids on cytokine
production in humans
Table 6 presents an overview of human studies con
cerning the effects of (n-3) fatty acids on cytokine pro
duction. In several studies peripheral blood mononu-
clear cells were isolated and profound decreases in ex
vivo production of IL-1, TNF and IL-6 were noted (En-
dres et al. 1989, Meydani et al. 1991). Unfortunately,
these studies did not employ a placebo group taking an
isoenergetic amount of a fatty acid supplement low in
polyunsaturated fatty acids and a (n-6) to (n-3) ratio
similar to that in the subjects' normal diet. Meydani
et al. (1993) reported on cytokine production capacity
in 22 subjects before and after 24 wk of a low fat diet.
The diets were either low or high in (n-3) fatty acids,
which were provided as natural food components. Ex
vivo production of IL-1/3, TNF and IL-6 by isolated pe
ripheral blood mononuclear cells fell significantly in
the high (n-3) fatty acids group. In contrast, IL-1/3 and
TNF production increased in the low (n-3) fatty acids
group. The two groups were not studied simultane
ously, as the authors state, to avoid seasonal differ
ences. Molvig et al. (1991) studied ex vivo cytokine
production after low and high dose dietary fish oil sup
plementations in healthy young men and in subjects
with diabetes. Control subjects took an isoenergetic
amount of a triglycÃ©rideblend. After 7 wk of oil supple
mentation, concentrations of secreted IL-iÃŸand of se
creted and cell-associated TNF were not different be
tween groups. Only cell-associated IL-1/3 was decreased
in the fish oil group. This finding is surprising, because
it is IL-la that remains cell associated whereas IL-1/3
is mainly released into the culture medium (Lonnem-
ann et al. 1989). In contrast with the findings of Endres
et al. (1989) no differences in ex vivo cytokine produc
tion were noted between the groups 10 wk after cessa
tion of the diet. Even though the authors had an appro
priate control group, the conclusions from this study
should be viewed with caution. This is because the
authors do not present the values from the start of the
study. Such a design (i.e., repeated measures) would
have greatly strengthened this study, because it can
help control for inherent intrasubject variation. In
other words, it is the changes in cytokine production
that (n-3) fatty acids cause that is really most important
and not the absolute amount of cytokine made by each
subject. In a study of rheumatoid arthritis patients, IL-
1 fell over time in all groups, including the control
group taking olive oil (Kremer et al. 1990). Cooper et al.
(1993) studied young volunteers before and after dietary
supplementation with fish oil during 6 to 8 wk. A con
current control group did not alter their usual diets.
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CYTOKINES AND (n-3) FATTY ACIDS 1525
Using a somewhat different method of cytokine mea
surement (whole blood culture), they found that ex
vivo production of IL-1 and IL-6 was suppressed after
fish oil supplementation. However, production of TNF
was not significantly altered. Interestingly, these inves
tigators found an attenuation of the inflammatory re
sponse to an intramuscular injection of typhoid vaccine
in the fish oil group. Recently, Cannon et al. (1995)
found no differences in ex vivo stimulated IL-IÃŸpro
duction in older subjects after 4 mo of dietary fish oil
supplementation compared with controls taking a pla
cebo of neutral fat composition. Again, in this study
no conclusions can be drawn about changes in cytokine
concentrations induced by fish oil, and possible effects
may be masked by intersubject variations. Espersen et
al. (1992) reported a reduction in plasma IL-1/3 concen
trations after fish oil supplementation in rheumatoid
arthritis patients that did not occur in the concurrent
control group.
In the Endres-Meydani (Endres et al. 1989, Meydani
et al. 1991 and 1993) peripheral blood mononuclear
cells were cultured in the presence of autologous serum
or plasma, whereas in Cannon's and Molvig's studies
(Cannon et al. 1995, Molvig et al. 1991 ), pooled normal
human serum was used. Theoretically, the fatty acids
present in the autologous serum could have influenced
the in vitro cytokine production. However, preincuba-
tion of human peripheral blood mononuclear cells with
eicosapentanoic acid resulted only in a marginal sup
pression of IL-1/0 synthesis, whereas TNF synthesis
was not affected at all (Sinha et al. 1991).
Whether (n-3) fatty acids reduce inflammation in cer
tain human disease states through inhibition of cytokine
production remains speculative, but most studies, con
trolled or not, report a decrease in one or more pro-in
flammatory cytokines after dietary (n-3) fatty acids.
(n-3) fatty acids and cytokine production in
animals
Animal studies concerning the production of cyto
kines after dietary (n-3) polyunsaturated fatty acid sup
plementation are summarized in Table 7.
Rats. Billiar et al. (1988) reported decreased bioac-
tivity of IL-1 and TNF produced in vitro by liver macro
phages of rats after 6 wk of dietary supplementation
with fish oil. Control animals were fed an equal
amount of corn oil. However, animals receiving saf-
flower oil, which is rich in (n-6) polyunsaturated fatty
acids, showed a decrease in IL-1 and TNF production
similar to that in animals fed fish oil. This latter find
ing is difficult to interpret, because in both corn oil
and safflower oil the predominant fatty acid is linoleic
acid. Grimm et al. (1994) also found decreased produc
tion of IL-6 and TNF in peripheral blood mononuclear
cells of rats fed (n-3) fatty acids for 4 d.
In contrast to these findings, Turek et al. (1991) re
ported increased TNF production capacity of resident
peritoneal macrophages in rats fed linseed oil for 30 d.
Linseed oil is rich in a-linolenic acid, an (n-3) fatty acid
and precursor of eicosapentanoic acid. Control animals
received com oil. Interestingly, when the peritoneal cells
were elicited by the in vivo administration of complete
Freund's adjuvant, the differences in TNF production in
the two dietary groups were no longer apparent.
Mice. There seems to be a contrast between the ef
fects of (n-3) fatty acids on cytokine production in mice
and in the other species studied. Watanabe et al. (1991)
studied the effects of feeding a-linolenic acid on TNF
production by murine peritoneal macrophages. Control
animals received safflower oil, rich in linoleic acid and
low in (n-3) fatty acids. Diets were given for 4 to 5 wk.
Endotoxin-stimulated TNF production by peritoneal
macrophages was significantly higher in the a-linole
nic acid group than in the control group. The authors
also reported a considerably higher serum TNF activity
in the a-linolenic acid group after in vivo injection of
endotoxin.
Lokesh et al. (1990) studied the synthesis of IL-1 and
TNF by mouse peritoneal macrophages after 4 wk of
dietary supplementation with fish oil, corn oil or olive
oil. An IL-1 bioassay was performed on the superna-
tants of cultured peritoneal macrophages stimulated
with endotoxin after lysis of the cells, and thus proba
bly reflected mainly IL-la. The TNF bioactivity was
measured in the supernatants of these macrophages.
Both IL-1 and TNF were markedly increased in the
mice fed fish oil compared with control animals. Simi
larly, Hardardottir and Kinsella (1992) found enhanced
in vitro stimulated TNF production by resident perito
neal macrophages in mice that had been fed an (n-3)
fatty acid-supplemented diet for 5 wk. Enlarging on
these observations, the same group studied the kinetics
of TNF release by in vitro-stimulated murine resident
peritoneal macrophages after 4 wk of fish oil or control
diet (Hardardottir et al. 1992). Although total TNF pro
duction was again increased, the kinetics of maximum
TNF production appeared not to be affected by the
diets. These findings were basically confirmed by Som-
ers and Erickson (1994).
Our group has studied ex vivo production of IL-1 and
TNF by peritoneal cells from mice fed fish oil, corn oil
or palm oil for 6 wk (Blok et al. 1992). Interleukin-la,
IL-IÃŸand TNF were measured by specific immunoas-
says. Interleukin-la and TNF production by peritoneal
cells were significantly higher in the fish oil-fed ani
mals than in controls (Fig. 2). Ertel et al. (1993) found
increased IL-1/? release by peritoneal macrophages of
mice following experimental hemorrhagic shock.
Thus, the effects of dietary (n-3) fatty acids on cyto
kine production in mice are opposite to those in hu
mans: in mice, several controlled studies have indepen
dently shown increased cytokine production after (n-
3) fatty acid supplementation, whereas in humans de
creased cytokine production was found. As can be seen
in Tables 6 and 7, human studies have exclusively used
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CYTOKINES AND (n-3) FATTY ACIDS 1527
peripheral blood cells, whereas most animal studies
(rats and mice) used isolated tissue macrophages. Thus,
as pointed out before, differences in origin of the cell
types used to study cytokine production may account
for the paradoxical responses to (n-3) fatty acids in hu
mans and animals. This hypothesis is supported by the
only animal study using peripheral blood mononuclear
cells, which found decreased IL-6 and TNF production
(Grimm et al. 1994). To clarify this issue, studies are
needed to evaluate the influence of dietary (n-3) fatty
acids on cytokine production in isolated peripheral
blood mononuclear cells and tissue macrophages si
multaneously.
As in the human studies, there is no evidence that
the alleviation of inflammation by (n-3) fatty acids in
animal studies is mediated by alterations in cytokine
production. Studies employing (n-3) fatty acids simul
taneously with control measures such as agonists or
antagonists of cytokines have not been performed.
POSSIBLE MECHANISMS OF THE
MODULATION OF CYTOKINE
PRODUCTION BY DIETARY(n-3) FATTY ACID INTAKE
At present, the mechanisms by which dietary (n-3)
fatty acids modulate cytokine production have not
been elucidated. Until recently, the alleviation of in
flammation after the ingestion of (n-3) fatty acids has
mainly been attributed to a reduced production by leu
kocytes of the eicosanoids prostaglandin E2 (PGE2) and
leukotriene B4(LTB4). Inflammatory agonists stimulate
eicosanoid synthesis by enhancing the release of ara-
chidonic acid from the intracellular phospholipid pool
through activation of phospholipases. Subsequently,
the free arachidonic acid is metabolized into prosta-
glandins and leukotrienes by the enzymes cyclooxy-
genase and lipoxygenase, respectively. Eicosapentanoic
acid, one of the (n-3) polyunsaturated fatty acids found
in high concentrations in fish oil, is rapidly incorpo
rated into cell membrane phospholipids, where it re
places arachidonic acid as a substrate and is converted
into the biologically less active prostaglandin E3 (PGE3 )
and leukotriene B5 (LTBS) (Lee et al. 1985). Moreover,
(n-3) fatty acids have been shown to be poorly metabo
lized by cyclooxygenase, thereby reducing the total pro
duction of eicosanoids (Lee et al. 1985).
Prostaglandins. Changes in the production of the
eicosanoids PGE2 and LTB4 have been postulated as
mechanisms of altered cytokine production after di
etary fatty acid supplementation. In vitro addition of
PGE2 to human peripheral blood mononuclear cells in
hibits TNF production, probably by increasing intracel
lular cyclic AMP (Endres et al. 1991, Renz et al. 1988).
Initially, the in vitro production of IL-1 has also been
reported to be under inhibitory control of PGE2, but
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FIGURE 2 Cytokine production capacity of murine peri
toneal cells. Swiss mice were fed fish oil, palm oil or corn
oil for 6 wk. Peritoneal cells were isolated and cultured with
(dark bars) or without endotoxin (light bars). Tumor necrosis
factor (TNF ) was measured in the culture medium; interleu-
kin-la (IL-la) was measured after lysis of the cells. Both TNF
and IL-la were significantly higher in the fish oil-fed mice
than in those fed corn oil or palm oil (P < 0.05). Reproduced
with permission from Blok et al. (1992). LPS = lipopolysac-
charide.
since the availability of specific IL-1 assays it has be
come clear that in vitro IL-1 secretion is not inhibited
by PGE2 (Endres et al. 1991, Scales et al. 1989). In vivo
inhibition of PGE2 production by administration of a
cyclooxygenase inhibitor has been reported to increase
circulating concentrations of IL-6 and TNF during
acute endotoxinemia in humans (Spinas et al. 1991).
Because PGE2 concentrations are decreased following
consumption of an (n-3) fatty acid-rich diet, it is un
likely that prostaglandins play an important role in
the decreased TNF production observed in humans and
some other species. In mice, however, decreased PGE2
production could account for the observed increases in
TNF after (n-3) fatty acids. Two groups reported that
the increase in TNF production by peritoneal macro
phages from mice fed fish oil or control diets could be
substantially reduced by treating these cells with PGE2
(Hardardottir and Kinsella 1991, Hubbard et al. 1991).
However, TNF production capacity was still elevated
in the mice fed (n-3) fatty acids compared with controls.
Hardardottir and Kinsella 1991) also showed that after
the abolition of PGE2 production in all dietary groups
by indomethacin, peritoneal macrophages of fish oil-
fed mice still produced significantly more TNF. This
indicates that in mice, reduced PGE2 production is not
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the only mechanism responsible for the increased TNF
production.
Leukotrienes. As suggested by Endres et al. (1989),
a fish oil-induced decrease in the synthesis of lipoxy-
genation products of arachidonic acid may account for
inhibition of cytokine production. However, studies on
the effect of leukotrienes on IL-1 production have
shown divergent results. Leukotriene B4 was reported
to enhance lipopolysaccharide-induced IL-1 production
by human monocytes in vitro (Rola-Pleszczynski and
Lemaire 1985), but specific leukotriene inhibitors
failed to reduce IL-1 production by human and mouse
mononuclear cells at concentrations that completely
inhibited leukotriene synthesis (Hoffman et al. 1991,
Parkar et al. 1990). In mice, treatment with lipoxygen-
ase inhibitors suppressed the circulating TNF concen
trations after endotoxin injection as well as the ex vivo
TNF production by peritoneal macrophages (Schade et
al. 1989). Endres et al. (1989) suggested that the pro
found decrease in IL-1 and TNF production at 10 wk
after cessation of the fish oil diet might have been due
to reduced production of LTB4. However, others re
ported complete restoration of LTB4 formation by neu-
trophils and peripheral blood mononuclear cells within
8 wk after cessation of a similar diet (Tulleken et al.
1989). These data suggest that reduced synthesis of leu
kotrienes is unlikely to cause the reduced cytokine pro
duction after (n-3) fatty acid administration.
Dual inhibition. Studies with agents that inhibit
both the lipoxygenase- and cyclooxygenase-mediated
metabolism of arachidonic acid are of interest, because
dietary (n-3) fatty acid supplementation results in a
similar reduction of both prostaglandins and leuko
trienes. One of these agents, tebufelone, enhanced IL-
1 and TNF synthesis by human peripheral blood mono-
nuclear cells at concentrations that suppressed leuko
triene formation (Sirko et al. 1991). Another dual
cyclooxygenase/lipoxygenase inhibitor, SK&F 86002,
protected mice from endotoxin-induced mortality and
reduced circulating TNF concentrations (Badger et al.
1989). Differences in species studied may account for
these divergent findings. However, because dual
cyclooxygenas/lipoxygenase inhibitors seem to in
crease cytokine production in human cells and de
crease cytokine production in mice, these observations
are opposite to the observed decrease in cytokine pro
duction in humans and the increased cytokine produc
tion in mice induced by (n-3) fatty acids. Thus, these
observations again argue against reduced eicosanoid
synthesis as an explanation for these effects.
Vitamin E and cytokine production. Fish oil con
centrates used in clinical and experimental studies are
enriched in vitamin E to prevent lipid peroxidation.
The effects of dietary fish oil supplementation on cyto
kine production could thus theoretically be due to the
vitamin E rather than to the (n-3) fatty acids.
Meydani et al. (1989) studied this issue in a group
of elderly human volunteers who consumed 800 iu of
all-rac-a-tocopheryl acetate daily for 30 d. Endotoxin-
stimulated IL-1 bioactivity was not affected by this vi
tamin E supplementation. Cannon et al. (1991) studied
male volunteers who supplemented their diets with
800 iu of all-rac-a-tocopherol daily for 48 d. After a
session of heavy exercise, IL-1/3 production capacity
rose in subjects receiving placebo but not in vitamin E-
supplemented subjects. The TNF production capacity
was not affected by vitamin E; IL-6 production capacity
was, however, significantly reduced in the vitamin E
group. These studies show that vitamin E supplemen
tation in itself may exert sortie influence on cytokine
production. However, the amount of vitamin E em
ployed in these studies is much higher than that in
gested in the fish oil studies (800 iu vs. approximately
20 lU/d). Therefore it remains questionable whether
vitamin E may account for the changes observed after
dietary fish oil supplementation.
Modulation of signal transduction. Some studies
have addressed the question whether (n-3) fatty acids
alter intracellular signal transduction pathways in
volved in the synthesis of cytokines. In mice, 10 d of
dietary supplementation with (n-3) fatty acids signifi
cantly increased the diacylglycerol concentration in
concanavalin A-stimulated splenocytes (Fowler et al.
1993). The (n-3) fatty acids seemed to modulate the
activities of protein kinase C and cAMP-dependent pro
tein kinases in a lymphoma cell line (Speizer et al.
1991). It is thus conceivable that (n-3 (fatty acids induce
changes in the concentrations or activities of intracel
lular factors involved in cytokine production. Clearly,
these data need to be confirmed and related to changes
in cytokine production.
CONCLUSIONS
Anti-inflammatory effects of dietary fish oil supple
mentation have been observed in clinical studies of
rheumatoid arthritis, psoriasis and ulcerative colitis.
The effects of (n-3) fatty acids seem to be stronger in
animal models of chronic inflammation than in the
clinical studies. This may relate to the early institution
of supplementation and the very high intake of (n-3)
fatty acids in the animal studies. In humans, the anti-
inflammatory potential of fish oil seems to be limited.
Studies in critically ill burn or postoperative cancer
patients yielded inconclusive results, but one study in
trauma patients is promising. It is unclear whether the
anti-inflammatory effects of fish oil in humans are me
diated through a reduction in cytokine production or
through other mechanisms such as reduced production
of lipid mediators; studies in humans have reported
impressive reductions in cytokine production capacity,
although not all studies were properly controlled. The
data from animal studies show the opposite: increased
IL-1 and TNF production capacity after (n-3) fatty acid
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supplementation. Differences in origin of cytokine-pro-
ducing cells may account for this paradoxical response
to (n-3) fatty acids in humans and mice.
Interference with the negative feedback of prosta-
glandins on TNF production partly accounts for the
increased TNF production after (n-3) fatty acid supple
mentation in mice. The mechanism of action of (n-3)
fatty acids on IL-1 production in mice and on cytokine
production in other species remains to be elucidated.
The issue whether dietary (n-3) fatty acids decrease
host resistance to infections is still unresolved. T cell
responses increased in certain patient groups after (n-
3) fatty acid consumption but decreased in healthy sub
jects. Baseline T cell activation may play a role here.
Some animal studies suggest a beneficial effect of (n-
3) fatty acids on outcome of infections, whereas others
report an adverse or no effect. Thus, at present there is
no firm scientific evidence that enterai feedings en
riched in (n-3)fatty acids are of benefit in the treatment
of critically ill patients. Future research in this field
may be directed in several ways. First, studies are
needed to relate the contributions of the various lipid
mediators and the intracellular signal transduction sys
tems to the observed effects of (n-3) fatty acids on in
flammation and on cytokine production. Second, differ
ent cytokine-producing cell types should be studied si
multaneously in one species to unravel the paradoxical
responses to dietary (n-3) fatty acids in humans and
mice. Third, in view of the preliminary studies already
performed and given the increasing number of immu-
nocompromised patients in our hospitals and intensive
care units, well-designed studies are needed to assess
the potential benefit of dietary (n-3) fatty acids in this
group of patients.
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